GlassScriptPhysician profile
Jose Rodriguez-Garcia
NPI 1396271912
$12,367.87
in general payments reported to CMS, 2019-2025
17 companies · $2,265 in 2025
The $2,265 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.75 · 2021: $46.41 · 2022: $917 · 2023: $2,041 · 2024: $7,084 · 2025: $2,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,940 · Food and Beverage: $4,160 · Travel and Lodging: $1,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,940.00 |
| Food and Beverage | $4,160.16 |
| Travel and Lodging | $1,290.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $9,590.39 | 2022-2025 | Descovy, Yeztugo |
| Viiv Healthcare Company | $1,072.83 | 2022-2025 | Apretude, Cabenuva, Dovato |
| Merck Sharp & Dohme LLC | $572.95 | 2020-2025 | Pifeltro, Delstrigo, Dificid |
| Theratechnologies INC. | $268.81 | 2023-2025 | Egrifta, Trogarzo |
| Napo Pharmaceuticals INC | $152.18 | 2023-2024 | Mytesi |
| Pfizer INC. | $126.46 | 2023 | |
| Emd Serono, INC. | $121.80 | 2021-2025 | Serostim |
| Janssen Scientific Affairs, LLC | $113.24 | 2023 | Symtuza |
| Janssen Biotech, INC. | $100.37 | 2021-2023 | Symtuza |
| Antares Pharma, INC. | $82.53 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Dynavax Technologies Corporation | $50.73 | 2022-2023 | Heplisav-B |
| Hologic Sales and Service, LLC | $35.52 | 2023 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $22.81 | 2022 | |
| Tolmar, INC. | $15.07 | 2024 | |
| Idorsia Pharmaceuticals US INC | $14.28 | 2023 | Quviviq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.95 | 2023 | |
| Novo Nordisk INC | $13.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rodriguez-Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.